David Einhorn Has 7 New Stock Picks: Hedge Fund Manager Bets on Buyouts, Spinoffs
A hedge fund is betting on spinoffs and buyouts for several of its new portfolio holdings.
Read original at benzingaStocks · News reference
Goldman Sachs Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $48
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $48.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 20, 2026, 9:34 AM
- Checked
- Jul 20, 2026, 9:34 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Argus Research Maintains Buy on Versigent, Raises Price Target to $54
Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.
Read original at benzingaEvercore ISI Group Maintains Outperform on Versigent, Raises Price Target to $65
Evercore ISI Group analyst Chris McNally maintains Versigent (NYSE:VGNT) with a Outperform and raises the price target from $60 to $65.
Read original at benzingaTD Cowen Maintains Buy on Versigent, Raises Price Target to $58
TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $49 to $58.
Read original at benzinga